News About: Pharm. Industry
Patent court rules against Sanofi-Aventis in patent suit
A patent court on Wednesday dismissed claims by French drug maker Sanofi-Aventis SA in a patent lawsuit against Boryung Pharmaceutical over their generic cancer medicine.
The court upheld the Korean Intellectual Pr...
More firms opt to recruit R&D personnel
Korean companies are concerned by the potentially significant impact of the government’s plan to cut drug prices by an average of 17 percent starting next year, which have caused them to tighten their belts on their o...
CJ files suit to nullify Viagra patent
CJ Cheiljedang Corp. said yesterday that it filed a lawsuit against US drug giant Pfizer's utility patent rights for Viagra, preserving Pfizer's market exclusivity on the drug into May 14, 2014.
The 2014 patent cov...
New dosage form of montelukast approved by KFDA
SK Chemicals said Tuesday that it has received the market authorization of montelukast ODF (oral disintegrating film) from the Korea Food and Drug Administration.
Montelukast is a leukotriene receptor antagonist (L...
Clinical trials are underway for 19 new drugs
Hana Daetoo Securities Co. says that Korea’s leading drug firms have carried out a total of 19 clinical trials abroad to develop new drugs.
SK Chemicals have led the other firms with 7 cases of clinical trials, fol...
Drastic price cut will weaken Korea’s R&D capability
The Korea Pharmaceutical Manufacturers Association said Monday that a drastic price cut would make domestic drug producers unable to invest in research and development (R&D), which is persuasive, given that they canno...
Can drug makers disclose actual management data?
The Ministry of Health and Welfare has asked pharmaceutical companies to submit their reliable management data, reflecting their predicaments due to the government’s plan to cut drug prices by an average of 17 percent...
New drug pricing reform to hurt local drug makers
Korean drug firms will no longer be safe from the corporate restructuring, after retail drug prices are to fall about 17 percent on average beginning next year following a set of government-led reforms, according to m...
Drug makers to collect anti-government signatures
The Korea Pharmaceutical Manufacturers Association (KPMA) unveiled its plan to continue to collect anti-government signatures from 1 million people, declaring an all-out struggle against the government’s plan to cut d...
Pharmaceutical firms to pin hopes on upcoming workshop
The Korea Pharmaceutical Manufacturers Association said Monday that its 20 member companies will hold an informal workshop with the Ministry of Health and Welfare between October 11 and 12 to discuss the government’s ...
